Practices


Taxotere MDL trial dates set

September 20, 2017 - Taxotere, a chemotherapy drug approved by the Food and Drug Administration (FDA) to treat breast cancer and other forms of cancer, has been linked to permanent hair loss. Read More


New trial for testosterone litigation starts next week

September 13, 2017 - Plaintiffs maintain that despite not being designed to treat symptoms of age-related testosterone decline, manufacturers marketed the products as “fountain of youth” drugs to lure men... Read More


More than 800 Physiomesh incidents filed with FDA report pain, suffering

September 6, 2017 - Since Physiomesh was first approved by the FDA in 2010, medical professionals have reported 839 adverse events, including injuries and at least nine deaths, naming the mesh device as the... Read More


No new trial for Janssen Pharmaceutical in $2.5 million Risperdal case

August 30, 2017 - The company was seeking a new trial as part of an effort to overturn a $2.5 million jury verdict that was awarded in 2015 to an Alabama man Austin Pledger. Read More


Navan Ward appointed to Plaintiffs Executive Committee for PPI litigation

August 25, 2017 - Proton Pump Inhibitor (PPI) drugs have been linked to kidney damage. Read More


Concern over Invokana adverse side effects continues to grow

August 25, 2017 - Reports of amputations connected to canagliflozin, the key ingredient in brand name medications Invokana and Invokamet, continue to underscore the drug’s dangers. Read More


New warning labels were evidence in $417 million talc-ovarian cancer win

August 23, 2017 - Other talcum powder products now warn women about the danger of genital use. Johnson & Johnson has declined to provide similar warnings on its Johnson’s Baby Powder, which contains talc... Read More


Why won’t J&J warn about talc ovarian cancer risk?

August 23, 2017 - Beasley Allen principal and founder Jere Beasley is calling on Johnson & Johnson to add an ovarian cancer warning to its talcum powder products like Johnson’s Baby Powder. Read More


Los Angeles jury links talc to ovarian cancer, awarding woman $417 million

August 21, 2017 - A Los Angeles jury awarded plaintiff Eva Echeverria $417 million, finding Johnson & Johnson talcum powder products responsible for her ovarian cancer. Read More


Retrievable IVC filter use down, but still high considering risks

August 16, 2017 - The use of retrievable inferior vena cava, or IVC, filters has fallen since the FDA issued a safety warning in 2010 about fracture and other adverse effects linked to the devices, but the... Read More


back to top